相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antiangiogenic agents in advanced gastrointestinal malignancies: past, present and a novel future
Oncotarget (2015)
FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells
Juan Du et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Cancer stem cells and EMT in carcinoma
Adrian Biddle et al.
CANCER AND METASTASIS REVIEWS (2012)
Polycomb Repressor Complex-2 Is a Novel Target for Mesothelioma Therapy
Clinton D. Kemp et al.
CLINICAL CANCER RESEARCH (2012)
Polycomb genes and cancer: Time for clinical application?
Francesco Crea et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2012)
Loading 3-deazaneplanocin A into pegylated unilamellar liposomes by forming transient phenylboronic acid-drug complex and its pharmacokinetic features in Sprague-Dawley rats
Feng Sun et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2012)
The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2
Fang Zheng et al.
GUT (2012)
3-Deazaneplanocin A is a promising therapeutic agent for the eradication of tumor-initiating hepatocellular carcinoma cells
Tetsuhiro Chiba et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer
Harry D. Bear et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Neoadjuvant Chemotherapy and Bevacizumab for HER2-Negative Breast Cancer
Gunter von Minckwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The Role of EZH2 in the Regulation of the Activity of Matrix Metalloproteinases in Prostate Cancer Cells
Yong Jae Shin et al.
PLOS ONE (2012)
Loss of Let-7 Up-Regulates EZH2 in Prostate Cancer Consistent with the Acquisition of Cancer Stem Cell Signatures That Are Attenuated by BR-DIM
Dejuan Kong et al.
PLOS ONE (2012)
Role of BMI1, a Stem Cell Factor, in Cancer Recurrence and Chemoresistance: Preclinical and Clinical Evidences
Hifzur Rahman Siddique et al.
STEM CELLS (2012)
S-adenosylhomocysteine hydrolase inhibition by 3-deazaneplanocin A analogues induces anti-cancer effects in breast cancer cell lines and synergy with both histone deacetylase and HER2 inhibition
Annette Hayden et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Decreased expression of EZH2 is associated with upregulation of ER and favorable outcome to tamoxifen in advanced breast cancer
E. A. Reijm et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Coordinated Regulation of Polycomb Group Complexes through microRNAs in Cancer
Qi Cao et al.
CANCER CELL (2011)
EZH2 Promotes Expansion of Breast Tumor Initiating Cells through Activation of RAF1-β-Catenin Signaling
Chun-Ju Chang et al.
CANCER CELL (2011)
Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer
Bo Zhang et al.
CARCINOGENESIS (2011)
(-)-Epigallocatechin-3-gallate and DZNep reduce polycomb protein level via a proteasome-dependent mechanism in skin cancer cells
Subhasree Roy Choudhury et al.
CARCINOGENESIS (2011)
Phosphorylation of EZH2 by CDK1 and CDK2 A possible regulatory mechanism of transmission of the H3K27me3 epigenetic mark through cell divisions
Xianzhuo Zeng et al.
CELL CYCLE (2011)
Polycomb protein EZH2 regulates cancer cell fate decision in response to DNA damage
Z. Wu et al.
CELL DEATH AND DIFFERENTIATION (2011)
Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancer
Francesco Crea et al.
MOLECULAR CANCER (2011)
Metastasis: new perspectives on an old problem
Sandra Kraljevic Pavelic et al.
MOLECULAR CANCER (2011)
FGF-2 Regulates Cell Proliferation, Migration, and Angiogenesis through an NDY1/KDM2B-miR-101-EZH2 Pathway
Filippos Kottakis et al.
MOLECULAR CELL (2011)
Tumor angiogenesis: molecular pathways and therapeutic targets
Sara M. Weis et al.
NATURE MEDICINE (2011)
MEK-ERK pathway regulates EZH2 overexpression in association with aggressive breast cancer subtypes
S. Fujii et al.
ONCOGENE (2011)
Down-Regulation of miR-101 in Endothelial Cells Promotes Blood Vessel Formation through Reduced Repression of EZH2
Michiel Smits et al.
PLOS ONE (2011)
MicroRNAs in the Pathogenesis of Cancer
Francesca Lovat et al.
SEMINARS IN ONCOLOGY (2011)
The physics of cancer: the role of physical interactions and mechanical forces in metastasis
Denis Wirtz et al.
NATURE REVIEWS CANCER (2011)
Should progression-free survival be the primary measure of efficacy for advanced NSCLC therapy?
J. C. Soria et al.
ANNALS OF ONCOLOGY (2010)
Bevacizumab in metastatic breast cancer: a meta-analysis of randomized controlled trials
A. Valachis et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Stage II and Stage III Colon Cancer Treatment Advances and Future Directions
Benoit Rousseau et al.
CANCER JOURNAL (2010)
Ixabepilone Plus Capecitabine for Breast Cancer Patients With an Early Metastatic Relapse After Adjuvant Chemotherapy: Two Clinical Trials
Monica Fornier
CLINICAL BREAST CANCER (2010)
Hypoxia and Hypoxia-Inducible Factors: Master Regulators of Metastasis
Xin Lu et al.
CLINICAL CANCER RESEARCH (2010)
MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion
Hui-Ju Wang et al.
EUROPEAN JOURNAL OF CANCER (2010)
Clinical significance of Polycomb gene expression in brain tumors
Francesco Crea et al.
MOLECULAR CANCER (2010)
Biomarkers to predict the clinical efficacy of bevacizumab in cancer
Adrian M. Jubb et al.
LANCET ONCOLOGY (2010)
Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells
Lucia Ricci-Vitiani et al.
NATURE (2010)
An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-κB
Junxia Min et al.
NATURE MEDICINE (2010)
EZH2 and STAT6 expression profiles are correlated with colorectal cancer stage and prognosis
Cheng-Gang Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis
Michiel Smits et al.
ONCOTARGET (2010)
Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells
Warren Fiskus et al.
BLOOD (2009)
Panobinostat treatment depletes EZH2 and DNMT1 levels and enhances decitabine mediated de-repression of JunB and loss of survival of human acute leukemia cells
Warren Fiskus et al.
CANCER BIOLOGY & THERAPY (2009)
Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
John M. L. Ebos et al.
CANCER CELL (2009)
EZH2 Is Essential for Glioblastoma Cancer Stem Cell Maintenance
Mario-Luca Suva et al.
CANCER RESEARCH (2009)
Transient RNA silencing of tissue factor pathway inhibitor-2 modulates lung cancer cell invasion
Sophie Iochmann et al.
CLINICAL & EXPERIMENTAL METASTASIS (2009)
Epigenetic gene regulation in stem cells and correlation to cancer
Lesley A. Mathews et al.
DIFFERENTIATION (2009)
DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation
Tina Branscombe Miranda et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Low-dose metronomic cyclophosphamide combined with vascular disrupting therapy induces potent antitumor activity in preclinical human tumor xenograft models
Laura G. Daenen et al.
MOLECULAR CANCER THERAPEUTICS (2009)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
Anchorage-independent cytokinesis as part of oncogenic transformation?
Minna Thullberg et al.
CELL CYCLE (2008)
Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome
Richard W. Tothill et al.
CLINICAL CANCER RESEARCH (2008)
Synergistic Antitumor Activity of Ixabepilone (BMS-247550) Plus Bevacizumab in Multiple In vivo Tumor Models
Francis Y. F. Lee et al.
CLINICAL CANCER RESEARCH (2008)
Pathways Mediating Resistance to Vascular Endothelial Growth Factor - Targeted Therapy
Lee M. Ellis et al.
CLINICAL CANCER RESEARCH (2008)
Cancer Stem Cells: The Seeds of Metastasis?
Elaine M. Hurt et al.
MOLECULAR INTERVENTIONS (2008)
Molecular origins of cancer: Tumor angiogenesis
Robert S. Kerbel
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer
Sooryanarayana Varambally et al.
SCIENCE (2008)
Modes of resistance to anti-angiogenic therapy
Gabriele Bergers et al.
NATURE REVIEWS CANCER (2008)
Epithelial-mesenchymal and mesenchymal - Epithelial transitions in carcinoma progression
Honor Hugo et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Pharmacologic disruption of polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells
Jing Tan et al.
GENES & DEVELOPMENT (2007)
Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors
Chris Folkins et al.
CANCER RESEARCH (2007)
Gene alterations identified by expression profiling in tumor-associated endothelial cells from invasive ovarian carcinoma
Chunhula Lu et al.
CANCER RESEARCH (2007)
The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells
JL Su et al.
CANCER CELL (2006)
Deciphering cellular states of innate tumor drug responses
E Graudens et al.
GENOME BIOLOGY (2006)
The gene associated with trichorhinophalangeal syndrome in humans is overexpressed in breast cancer
L Radvanyi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Bevacizurnab in combination with fluorouracil and leucovorin: An active regimen for first-line metastatic colorectal cancer
HI Hurwitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Gene expression signature predicts lymphatic metastasis in squamous cell carcinoma of the oral cavity
RK O'Donnell et al.
ONCOGENE (2005)
Gene expression profiling identifies clinically relevant subtypes of prostate cancer
J Lapointe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
ONCOMINE: A cancer microarray database and integrated data-mining platform
DR Rhodes et al.
NEOPLASIA (2004)
Variation in gene expression patterns in human gastric cancers
X Chen et al.
MOLECULAR BIOLOGY OF THE CELL (2003)
A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2
JH Qi et al.
NATURE MEDICINE (2003)
Epithelial-mesenchymal transitions in tumour progression
JP Thiery
NATURE REVIEWS CANCER (2002)
分享论文
